IRIS Accounts Production v25.4.0.155 13940189 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false A Ordinary 1.00000 B Ordinary 1.00000 C Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh139401892024-03-31139401892025-03-31139401892024-04-012025-03-31139401892023-03-31139401892023-04-012024-03-31139401892024-03-3113940189ns15:EnglandWales2024-04-012025-03-3113940189ns14:PoundSterling2024-04-012025-03-3113940189ns10:Director12024-04-012025-03-3113940189ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3113940189ns10:SmallEntities2024-04-012025-03-3113940189ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3113940189ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3113940189ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3113940189ns10:FullAccounts2024-04-012025-03-3113940189ns10:OrdinaryShareClass22024-04-012025-03-3113940189ns10:OrdinaryShareClass32024-04-012025-03-3113940189ns10:OrdinaryShareClass42024-04-012025-03-3113940189ns10:Director22024-04-012025-03-3113940189ns10:RegisteredOffice2024-04-012025-03-3113940189ns5:CurrentFinancialInstruments2025-03-3113940189ns5:CurrentFinancialInstruments2024-03-3113940189ns5:Non-currentFinancialInstruments2025-03-3113940189ns5:Non-currentFinancialInstruments2024-03-3113940189ns5:ShareCapital2025-03-3113940189ns5:ShareCapital2024-03-3113940189ns5:RetainedEarningsAccumulatedLosses2025-03-3113940189ns5:RetainedEarningsAccumulatedLosses2024-03-3113940189ns5:MotorVehicles2024-04-012025-03-3113940189ns5:MotorVehicles2025-03-3113940189ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3113940189ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3113940189ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2025-03-3113940189ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-03-3113940189ns5:HirePurchaseContractsns5:BetweenOneFiveYears2025-03-3113940189ns5:HirePurchaseContractsns5:BetweenOneFiveYears2024-03-3113940189ns5:HirePurchaseContracts2025-03-3113940189ns5:HirePurchaseContracts2024-03-3113940189ns10:OrdinaryShareClass22025-03-3113940189ns10:OrdinaryShareClass32025-03-3113940189ns10:OrdinaryShareClass42025-03-31139401892ns10:Director22024-03-31139401892ns10:Director22023-03-31139401892ns10:Director22024-04-012025-03-31139401892ns10:Director22023-04-012024-03-31139401892ns10:Director22025-03-31139401892ns10:Director22024-03-31
REGISTERED NUMBER: 13940189 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

ARJUN HEALTHCARE LIMITED

ARJUN HEALTHCARE LIMITED (REGISTERED NUMBER: 13940189)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


ARJUN HEALTHCARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: Dr S Patel
Dr K Patel





REGISTERED OFFICE: 12 Victoria Road
Barnsley
United Kingdom
S70 2BB





REGISTERED NUMBER: 13940189 (England and Wales)





ACCOUNTANTS: Gibson Booth Limited
12 Victoria Road
Barnsley
South Yorkshire
S70 2BB

ARJUN HEALTHCARE LIMITED (REGISTERED NUMBER: 13940189)

BALANCE SHEET
31 MARCH 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 39,592 -

CURRENT ASSETS
Debtors 5 12,910 6,780
Cash at bank 2,440 4,184
15,350 10,964
CREDITORS
Amounts falling due within one year 6 18,703 10,430
NET CURRENT (LIABILITIES)/ASSETS (3,353 ) 534
TOTAL ASSETS LESS CURRENT LIABILITIES 36,239 534

CREDITORS
Amounts falling due after more than one
year

7

13,190

-
NET ASSETS 23,049 534

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 22,949 434
SHAREHOLDERS' FUNDS 23,049 534

ARJUN HEALTHCARE LIMITED (REGISTERED NUMBER: 13940189)

BALANCE SHEET - continued
31 MARCH 2025


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 November 2025 and were signed on its behalf by:





Dr K Patel - Director


ARJUN HEALTHCARE LIMITED (REGISTERED NUMBER: 13940189)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1. STATUTORY INFORMATION

Arjun Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest pound.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
No judgements have been made in the process of applying the below accounting policies that have had the most significant effect on amounts recognised in the financial statements.

There are no key assumptions concerning the future and other key sources of estimation uncertainty at the reporting date that have a significant risk of causing material adjustment to the carrying amounts of assets and liabilities within the next financial year.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost, less estimated residual value, of each asset on a systematic basis over its expected useful life as follows:

Motor vehicles- 20% reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


ARJUN HEALTHCARE LIMITED (REGISTERED NUMBER: 13940189)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4. TANGIBLE FIXED ASSETS
Motor
vehicles
£   
COST
Additions 44,717
At 31 March 2025 44,717
DEPRECIATION
Charge for year 5,125
At 31 March 2025 5,125
NET BOOK VALUE
At 31 March 2025 39,592

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 7,701 6,780
Other debtors 1,000 -
Directors' current accounts 4,209 -
12,910 6,780

ARJUN HEALTHCARE LIMITED (REGISTERED NUMBER: 13940189)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Hire purchase contracts (see note 8) 11,010 -
Corporation tax 6,254 8,129
Directors' current accounts - 1,251
Accruals and deferred income 1,439 1,050
18,703 10,430

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.3.25 31.3.24
£    £   
Hire purchase contracts (see note 8) 13,190 -

8. LEASING AGREEMENTS

Minimum lease payments under hire purchase fall due as follows:

31.3.25 31.3.24
£    £   
Net obligations repayable:
Within one year 11,010 -
Between one and five years 13,190 -
24,200 -

The finance liability is secured on the asset to which it relates.

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.25 31.3.24
value: £    £   
40 A Ordinary £1 40 40
40 B Ordinary £1 40 40
20 C Ordinary £1 20 20
100 100

ARJUN HEALTHCARE LIMITED (REGISTERED NUMBER: 13940189)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

31.3.25 31.3.24
£    £   
Dr S Patel
Balance outstanding at start of year (1,251 ) (789 )
Amounts advanced 56,326 -
Amounts repaid (50,866 ) (462 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 4,209 (1,251 )